Estrogen-induced apoptosis in a breast cancer model resistant to long-term estrogen withdrawal
- 28 February 2005
- journal article
- Published by Elsevier BV in The Journal of Steroid Biochemistry and Molecular Biology
- Vol. 94 (1-3), 131-141
- https://doi.org/10.1016/j.jsbmb.2004.12.032
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Emerging Role of Aromatase Inhibitors in the Adjuvant SettingAmerican Journal of Clinical Oncology, 2003
- Tamoxifen: a most unlikely pioneering medicineNature Reviews Drug Discovery, 2003
- Overview of the main outcomes in breast-cancer prevention trialsThe Lancet, 2003
- Phase III, Multicenter, Double-Blind, Randomized Study of Letrozole, an Aromatase Inhibitor, for Advanced Breast Cancer Versus Megestrol AcetateJournal of Clinical Oncology, 2001
- Aromatase Inhibitors in the Treatment and Prevention of Breast CancerJournal of Clinical Oncology, 2001
- Exemestane improves survival compared with megoestrol acetate in postmenopausal patients with advanced breast cancer who have failed on tamoxifen: results of a double-blind randomised phase III trialEuropean Journal Of Cancer, 2000
- Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 StudyJNCI Journal of the National Cancer Institute, 1998
- Tamoxifen for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Aromatease, its inhibitors and their use in breast cancer treatmentPharmacology & Therapeutics, 1993
- ON THE TREATMENT OF INOPERABLE CASES OF CARCINOMA OF THE MAMMA: SUGGESTIONS FOR A NEW METHOD OF TREATMENT, WITH ILLUSTRATIVE CASES.1The Lancet, 1896